Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
11/2007
11/29/2007WO2007106537A3 Aminoquinolones as gsk-3 inhibitors
11/29/2007WO2007090749A3 Benzamide and heteroarene derivatives as cetp inhibitors
11/29/2007WO2007089735A3 Potassium channel inhibitors
11/29/2007WO2007084413A3 Methods for treating hepatitis c
11/29/2007WO2007075895A3 Heterocyclic derivatives as modulators of ion channels
11/29/2007WO2007045893A3 Beta adrenergic receptor pharmacophore
11/29/2007WO2007035722A8 Methods and compositions for stimulating neurogenesis and inhibiting neuronal degeneration
11/29/2007WO2007006594A3 Reactive azo dyes, methods for the production thereof and their use
11/29/2007WO2006106326A8 Substituted heterocycles and their use as chk1, pdk1 and pak inhibitors
11/29/2007WO2006095159A8 (imidazolo-5-yl)-2-anilo-pyrimidines as agents for the inhibition of cell proliferation
11/29/2007US20070276141 Preparation of Pharmaceutical Salts of [1,4] - Bipiperidine
11/29/2007US20070276140 Chiral 1,8-Diarylnaphthalenes, Methods of Making Them, and Their Use as Sensors
11/29/2007US20070276104 Containing substituted or unsubstituted bipyridine, tripyridine, or phenanthroline groups, e.g., Di-[p-(2,2':6',2'')terpyridin-4'-ylbenzyl] 4,4'-azobis(4-cyanovalerate) and N,N'-di-[1,10-phenanthrolin-5-yl]-4,4'-azobis(4-cyanovalerylamide); RAFT polymerization catalysts
11/29/2007US20070276010 benzyl-carbamic acid cis-3-[5-(cyclohexanecarbonyl-amino)-1H-pyrazol-3-yl]-cyclobutyl ester; glycogen synthase kinase-3 (GSK-3) inhibitors; inter alia, Alzheimer's Disease, cancer, dementia, depression, diabetes, hair loss, schizophrenia, and stroke
11/29/2007US20070276009 Compositions and Methods for Viral Inhibition
11/29/2007US20070276003 Biphenyl-2-ylcarbamic acid 1-{7-[(R)-2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethylamino]heptyl}piperidin-4-yl ester; beta 2 adrenergic receptor agonist and muscarinic receptor antagonist; bronchodilator agent; pulmonary disorders, chronic obstructive pulmonary disease and asthma
11/29/2007US20070276001 Biphenyl-pyrazolecarboxamide compounds
11/29/2007US20070275988 Transition state structure and inhibitors of thymidine phosphorylases
11/29/2007US20070275981 (Hetero)Cyclycarboxamides for Controlling Pathogenic Fungi
11/29/2007US20070275968 Substituted Biphenyl Derivative
11/29/2007US20070275967 Pyrazolinols
11/29/2007US20070275965 CXCR4 modulators
11/29/2007US20070275964 Cannabinoid receptor ligands and uses thereof
11/29/2007US20070275956 Novel Heterocyclic Compounds
11/29/2007US20070275952 Tie-2 Modulators and Methods of Use
11/29/2007US20070275950 2-Phenylpyridine Derivative
11/29/2007US20070275946 Cytokine Inhibitors
11/29/2007US20070275932 Aryl, heteroaromatic and bicyclic aryl nitrone compounds, prodrugs and pharmaceutical compositions of the same to treat human disorders
11/29/2007US20070275911 Targeted Drug-Formaldehyde Conjugates and Methods of Making and Using the Same
11/29/2007US20070272777 Processes for reducing particle size of aripiprazole
11/29/2007US20070271730 Magnet for loose friction checks to rods including those of basic door closers
11/29/2007DE102006024024A1 Substituierte Arylimidazolone und -triazolone sowie ihre Verwendung Substituted Arylimidazolone and -triazolone and their use
11/29/2007CA2652484A1 Heterocyclic type cinnamide derivative
11/29/2007CA2652443A1 1- [ (4- [benzoyl (methyl) amino] -3- (phenyl) butyl] azetidine derivatives for the treatment of gastrointestinal disorders 1
11/29/2007CA2652393A1 1,5-diphenylpyrazoles ii as hsp90 inhibitors
11/29/2007CA2651732A1 Intracellular kinase inhibitors
11/29/2007CA2651681A1 Aryl-fused spirocyclic compounds
11/29/2007CA2651396A1 Urea type cinnamide derivative
11/29/2007CA2650795A1 Novel microbiocides
11/29/2007CA2649913A1 N-benzoyl- and n-benzylpyrrolidin-3-ylamines as histamine-3 antagonists
11/29/2007CA2649707A1 Substituted pyrazinone derivatives for use as a medicine
11/29/2007CA2649196A1 New hydroxyphenyl derivatives and biological applications thereof
11/28/2007EP1860105A1 Process for the preparation of desloratadine
11/28/2007EP1860100A2 2-(1H-indolylsulfanyl)-benzyl amine derivatives as SSRI
11/28/2007EP1859798A1 N-(2-arylethyl) benzylamines as antagonists of the 5-ht6 receptor
11/28/2007EP1858895A2 Piperazine-piperidines with cxcr3 antagonist activity
11/28/2007EP1858888A2 Heteroaryl substituted pyrazinyl-piperazine-piperidines with cxcr3 antagonist activity
11/28/2007EP1858887A1 Piperidinyl piperazine derivatives useful as inhibitors of chemokine receptors
11/28/2007EP1858886A1 Piperidinyl piperidine derivatives useful as inhibitors of chemokine receptors
11/28/2007EP1858885A1 Indolylamino quinazoline derivatives as antitumor agents
11/28/2007EP1858884A1 Indazolylamino quinazoline derivatives as antitumor agents
11/28/2007EP1858883A2 Heterocyclic n-oxides as hypoxic selective protein kinase inhibitors
11/28/2007EP1858882A1 Pyrimidine derivatives for treatment of hyperproliferative disorders
11/28/2007EP1858881A1 Process for the preparation of optically active derivatives of 2-(2-pyridylmethylsulfinyl)-benzimidazole via inclusion complex with 1,1'-binaphthalene-2, 2'diol
11/28/2007EP1858880A1 Amido-substituted 6-phenylphenanthridines
11/28/2007EP1858879A1 1,3-diaryl substituted ureas as modulators of kinase activity
11/28/2007EP1858878A1 Conversion of 2-pyrazolines to pyrazoles using bromine
11/28/2007EP1858877A1 1,3 substituted diaryl ureas as modulators of kinase activity
11/28/2007EP1858876A2 Pyridinone derivatives against malaria
11/28/2007EP1858862A1 PYRAZINE -2-CARBOXAMIDE DERIVATIVES AS mGluR5 ANTAGONISTS
11/28/2007EP1858857A1 Azabicycloalkane derivatives useful as nicotinic acetylcholine receptor agonists
11/28/2007EP1858854A1 Pyridine-2-carboxamide derivatives as mglur5 antagonists
11/28/2007EP1858850A2 Process for the preparation of opioid modulators
11/28/2007EP1858849A1 Organic compounds
11/28/2007EP1858846A1 Dpp-iv inhibitors
11/28/2007EP1858520A2 Quinazolinone t-type calcium channel antagonists
11/28/2007EP1761516B1 2, 4, 5, 6-substituted pyrimidines, method for the production and use thereof for combating parasitic fungi
11/28/2007EP1725543B1 4-benzimidazol-2-yl-pyridazine-3-one-derivatives, production and use thereof in medicaments
11/28/2007EP1373257B1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
11/28/2007EP1293507B1 Process for producing crystal
11/28/2007EP1056723B1 2-pyridylmethylamine derivatives useful as fungicides
11/28/2007EP0948486B1 Pesticidal 1-arylpyrazoles
11/28/2007CN101080403A Novel hydantoin derivatives as metalloproteinase inhibitors
11/28/2007CN101080402A Hydantoin derivatives useful as metalloproteinase inhibitors
11/28/2007CN101080401A Substituted biaryl analogues
11/28/2007CN101080400A Processes for the preparation of substituted 2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolines
11/28/2007CN101080396A Quinoxalines as B Raf inhibitors
11/28/2007CN101080228A Piperazinyl-pyridine analogues
11/28/2007CN101080226A Amido compounds and their use as pharmaceuticals
11/28/2007CN101077875A Boronic ester and acid compounds, synthesis and uses
11/28/2007CN100351251C Indolylmaleimide derivatives
11/28/2007CN100351250C Nobel compounds having selective inhibiting effect at GSK3
11/28/2007CN100351249C Quinolinone derivatives as tyrosine kinase inhibitors
11/28/2007CN100351242C Processes and intermediates for preparing anti-cancer compounds
11/28/2007CN100351239C Pyrimidine derivatives and their use as CB2 modulators
11/28/2007CN100351237C Novel hererocyclic compound and preparation thereof and medicine composition containing same and use thereof in medicine
11/28/2007CN100351236C 1-heterocyclylalkyl-3-sulfonyl-indole or -indazole derivatives as 5-hydroxytryptamine-6 ligands
11/28/2007CN100351230C Urea of N-heterocyclic carboxylic acid or the isostere of carboxylic acid and aminocarboxylic acid ester
11/27/2007US7301030 Enantioselective sulphoxidation of 5-difluoromethoxy-2-[(3,4-dimethoxy-2-pyridinyl)methylthio]-1H-benzimidazole using cumene hydroperoxide in the presence of a chiral hafnium or zirconium complex; industrial scale
11/27/2007US7301029 Drugs; agricultural chemicals; electrography photosensitive materials
11/27/2007US7301028 Mitotic kinesin inhibitors
11/27/2007US7301024 Crystalline forms of gatifloxacin and processes for preparation
11/27/2007US7301022 N-(2-(6-7-hydroxy-5,6,7,8-tetrahydronaphthalen-1-ylamino)pyrimidin-4-yl)-5-(trifluoromethyl)phenyl)-1-isopropylpyrrolidine-2-carboxamide hydrochloride; antiinflammatory agents, analgesics, antiarthritic agents, antiulcer agents
11/27/2007US7300956 Acyloxyalkyl carbamate prodrugs, methods of synthesis and use
11/27/2007US7300948 Useful for the manufacture of a medicament for treating HIV infection in a human infected by HIV. The compounds are potent inhibitors of wild-type (WT) and double mutant strains of HIV-1 RT, particularly the double mutant K103N/Y181C; benzophenone derivatives
11/27/2007US7300946 For use in controlling insects; controlling tobacco budworm
11/27/2007US7300945 For therapy of of certain central nervous system (CNS) diseases, anxiety, depression, a sleep disorder, schizophrenia, or attention deficit-hyperactivity disorder
11/27/2007US7300941 Non-imidazole compounds
11/27/2007US7300938 Polymorphs of imatinib mesylate
11/27/2007US7300937 Derivatives of cyano-aryl (or cyanoheteroaryl)-carbonyl-piperazinyl-pyrimidines, their preparation and application as medication
1 ... 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 ... 1080